{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:13:05Z","timestamp":1777500785727,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T00:00:00Z","timestamp":1646524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T00:00:00Z","timestamp":1646524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Scientific research program of Health Commission of Shanxi Province","award":["2021070"],"award-info":[{"award-number":["2021070"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To validate a contrast-enhanced CT (CECT)-based radiomics model (RM) for differentiating various risk subgroups of thymic epithelial tumors (TETs).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective study was performed on 164 patients with TETs who underwent CECT scans before treatment. A total of 130 patients (approximately 79%, from 2012 to 2018) were designated as the training set, and 34 patients (approximately 21%, from 2019 to 2021) were designated as the testing set. The analysis of variance and least absolute shrinkage and selection operator algorithm methods were used to select the radiomics features. A logistic regression classifier was constructed to identify various subgroups of TETs. The predictive performance of RMs was evaluated based on receiver operating characteristic (ROC) curve analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Two RMs included 16 and 13 radiomics features to identify three risk subgroups of traditional risk grouping [low-risk thymomas (LRT: Types A, AB and B1), high-risk thymomas (HRT: Types B2 and B3), thymic carcinoma (TC)] and improved risk grouping [LRT* (Types A and AB), HRT* (Types B1, B2 and B3), TC], respectively. For traditional risk grouping, the areas under the ROC curves (AUCs) of LRT, HRT, and TC were 0.795, 0.851, and 0.860, respectively, the accuracy was 0.65 in the training set, the AUCs were 0.621, 0.754, and 0.500, respectively, and the accuracy was 0.47 in the testing set. For improved risk grouping, the AUCs of LRT*, HRT*, and TC were 0.855, 0.862, and 0.869, respectively, and the accuracy was 0.72 in the training set; the AUCs were 0.778, 0.716, and 0.879, respectively, and the accuracy was 0.62 in the testing set.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>CECT-based RMs help to differentiate three risk subgroups of TETs, and RM established according to improved risk grouping performed better than traditional risk grouping.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12880-022-00768-8","type":"journal-article","created":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T11:02:28Z","timestamp":1646564548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Contrast-enhanced CT-based radiomics model for differentiating risk subgroups of thymic epithelial tumors"],"prefix":"10.1186","volume":"22","author":[{"given":"Chunhai","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhikai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,6]]},"reference":[{"key":"768_CR1","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/JTO.0b013e3181f1f62d","volume":"5","author":"EA Engels","year":"2010","unstructured":"Engels EA. Epidemiology of thymoma and associated malignancies. J Thorac Oncol. 2010;5:260\u20135.","journal-title":"J Thorac Oncol"},{"key":"768_CR2","volume-title":"World Health Organization classification of tumours: pathology and genetics: tumours of the lung, pleura, thymus and heart","author":"WD Travis","year":"2004","unstructured":"Travis WD, Brambilla E, Burke AP, et al. World Health Organization classification of tumours: pathology and genetics: tumours of the lung, pleura, thymus and heart. 4th ed. Lyon: World Health Organization; 2004.","edition":"4"},{"key":"768_CR3","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/JTO.0000000000000154","volume":"9","author":"A Marx","year":"2014","unstructured":"Marx A, Str\u00f6bel P, Badve SS, et al. ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting. J Thorac Oncol. 2014;9:596\u2013611.","journal-title":"J Thorac Oncol"},{"key":"768_CR4","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1200\/JCO.2004.10.113","volume":"22","author":"P Strobel","year":"2004","unstructured":"Strobel P, Bauer A, Puppe B, et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol. 2004;22:1501\u20139.","journal-title":"J Clin Oncol"},{"key":"768_CR5","first-page":"153","volume":"62","author":"B Moser","year":"2014","unstructured":"Moser B, Scharitzer M, Hacker S, et al. Thymomas and thymic carcinomas: prognostic factors and multimodal management. Thorac Cardiovasc Surg. 2014;62:153\u201360.","journal-title":"Thorac Cardiovasc Surg"},{"key":"768_CR6","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.athoracsur.2003.07.042","volume":"77","author":"K Kondo","year":"2004","unstructured":"Kondo K, Yoshizawa K, Tsuyuguchi M, et al. WHO histologic classifcation is a prognostic indicator in thymoma. Ann Thorac Surg. 2004;77:1183\u20138.","journal-title":"Ann Thorac Surg"},{"key":"768_CR7","unstructured":"Ettinger DS, Wood DE, Aisner DL, et al. National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology: thymomas and thymic carcinomas, Version 1.2021. https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx#thymic. Accessed 4 Dec 2020."},{"key":"768_CR8","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1148\/rg.2017174002","volume":"37","author":"M Nishino","year":"2017","unstructured":"Nishino M, Ashiku SK, Kocher ON, et al. The thymus: a comprehensive review. Radiographics. 2017;37:1004.","journal-title":"Radiographics"},{"key":"768_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/RTI.0b013e31828609a0","volume":"28","author":"EM Marom","year":"2013","unstructured":"Marom EM. Advances in thymoma imaging. J Thorac Imaging. 2013;28:69\u201380.","journal-title":"J Thorac Imaging"},{"key":"768_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12194-017-0394-5","volume":"10","author":"B Van Ginneken","year":"2017","unstructured":"Van Ginneken B. Fifty years of computer analysis in chest imaging: rule-based, machine learning, deep learning. Radiol Phys Technol. 2017;10:23\u201332.","journal-title":"Radiol Phys Technol"},{"key":"768_CR11","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278:563\u201377.","journal-title":"Radiology"},{"key":"768_CR12","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/jmri.27444","volume":"53","author":"KE Fasmer","year":"2021","unstructured":"Fasmer KE, Hodneland E, Dybvik JA, et al. Whole-volume tumor MRI radiomics for prognostic modeling in endometrial cancer. J Magn Reson Imaging. 2021;53:928\u201337.","journal-title":"J Magn Reson Imaging"},{"key":"768_CR13","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00330-020-07141-9","volume":"31","author":"MR Chetan","year":"2021","unstructured":"Chetan MR, Gleeson FV. Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectives. Eur Radiol. 2021;31:1049\u201358.","journal-title":"Eur Radiol"},{"key":"768_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.semcancer.2020.04.002","volume":"72","author":"A Conti","year":"2021","unstructured":"Conti A, Duggento A, Indovina I, et al. Radiomics in breast cancer classification and prediction. Semin Cancer Biol. 2021;72:238\u201350.","journal-title":"Semin Cancer Biol"},{"key":"768_CR15","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.21037\/tlcr-20-477","volume":"9","author":"RJ Cerfolio","year":"2020","unstructured":"Cerfolio RJ, Moore WH. Can CT radiomics differentiate benign from malignant N2 adenopathy in non-small cell lung cancer. Transl Lung Cancer Res. 2020;9:1710\u20131.","journal-title":"Transl Lung Cancer Res"},{"key":"768_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40644-020-00364-5","volume":"20","author":"CY Ren","year":"2020","unstructured":"Ren CY, Li ML, Zhang YY, et al. Development and validation of a CT-texture analysis nomogram for preoperatively differentiating thymic epithelial tumor histologic subtypes. Cancer Imaging. 2020;20:86.","journal-title":"Cancer Imaging"},{"key":"768_CR17","first-page":"1256","volume":"43","author":"XM Chen","year":"2020","unstructured":"Chen XM, Feng B, Li CL, et al. A radiomics model to predict the invasiveness of thymic epithelial tumors based on contrast-enhanced computed tomography. Oncol Rep. 2020;43:1256\u201366.","journal-title":"Oncol Rep"},{"key":"768_CR18","doi-asserted-by":"publisher","first-page":"628534","DOI":"10.3389\/fonc.2021.628534","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu J, Yin P, Wang SC, et al. CT-based radiomics signatures for predicting the risk categorization of thymic epithelial tumors. Front Oncol. 2021;11:628534.","journal-title":"Front Oncol"},{"key":"768_CR19","first-page":"1","volume":"10","author":"YC Hu","year":"2014","unstructured":"Hu YC, Wu L, Yan LF, et al. Predicting subtypes of thymic epithelial tumors using CT: new perspective based on a comprehensive analysis of 216 patients. Sci Rep. 2014;10:1\u20137.","journal-title":"Sci Rep"},{"key":"768_CR20","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.jtcvs.2009.10.024","volume":"139","author":"HK Kim","year":"2010","unstructured":"Kim HK, Choi YS, Kim J, et al. Type B thymoma: is prognosis predicted only by World Health Organization classification? J Thorac Cardiovasc Surg. 2010;139:1431\u20135.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"768_CR21","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.21037\/jtd.2019.05.32","volume":"11","author":"He Sui","year":"2019","unstructured":"Sui He, Liu L, Li X, et al. CT-based radiomics features analysis for predicting the risk of anterior mediastinal lesions. J Thorac Dis. 2019;11(5):1809\u201318.","journal-title":"J Thorac Dis"},{"key":"768_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12957-021-02259-6","volume":"19","author":"A Kayi Cangir","year":"2021","unstructured":"Kayi Cangir A, Orhan K, Kahya Y, et al. CT imaging-based machine learning model: a potential modality for predicting low-risk and high-risk groups of thymoma: \u201cImpact of surgical modality choice.\u201d World J Surg Oncol. 2021;19:147.","journal-title":"World J Surg Oncol"},{"key":"768_CR23","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1097\/JTO.0000000000000654","volume":"10","author":"A Marx","year":"2015","unstructured":"Marx A, Chan JKC, Coindre J-M, et al. The 2015 WHO classification of tumors of the thymus: continuity and changes. J Thorac Oncol. 2015;10:1383\u201395.","journal-title":"J Thorac Oncol"},{"key":"768_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fonc.2018.00096","volume":"4","author":"A Chaddad","year":"2018","unstructured":"Chaddad A, Daniel P, Niazi T. Radiomics evaluation of histological heterogeneity using multiscale textures derived from 3D wavelet transformation of multispectral images. Front Oncol. 2018;4:96.","journal-title":"Front Oncol"},{"key":"768_CR25","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3389\/fonc.2019.01041","volume":"11","author":"X Han","year":"2019","unstructured":"Han X, Gao W, Chen Y, et al. Relationship between computed tomography imaging features and clinical characteristics, Masaoka-Koga stages, and World Health Organization histological classifications of thymoma. Front Oncol. 2019;11:1041.","journal-title":"Front Oncol"},{"key":"768_CR26","first-page":"3616852","volume":"28","author":"X Wang","year":"2019","unstructured":"Wang X, Sun W, Liang H, et al. Radiomics signatures of computed tomography imaging for predicting risk categorization and clinical stage of thymomas. Biomed Res Int. 2019;28:3616852.","journal-title":"Biomed Res Int"},{"key":"768_CR27","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1007\/s00330-016-4542-9","volume":"27","author":"S Chang","year":"2017","unstructured":"Chang S, Hur J, Im DJ, et al. Volume-based quantification using dual-energy computed tomography in the differentiation of thymic epithelial tumours: an initial experience. Eur Radiol. 2017;27:1992\u20132001.","journal-title":"Eur Radiol"},{"key":"768_CR28","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.1038\/s41598-020-62466-1","volume":"10","author":"CH Yu","year":"2020","unstructured":"Yu CH, Li T, Zhang RP, Yang X, et al. Dual-energy CT perfusion imaging for differentiating WHO subtypes of thymic epithelial tumors. Sci Rep. 2020;10:5511.","journal-title":"Sci Rep"},{"key":"768_CR29","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.ctrv.2020.102014","volume":"86","author":"F Conforti","year":"2020","unstructured":"Conforti F, Pala L, Giaccone G, et al. Thymic epithelial tumors: from biology to treatment. Cancer Treat Rev. 2020;86:1014.","journal-title":"Cancer Treat Rev"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-022-00768-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-022-00768-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-022-00768-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T11:03:38Z","timestamp":1646564618000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-022-00768-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,6]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["768"],"URL":"https:\/\/doi.org\/10.1186\/s12880-022-00768-8","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,6]]},"assertion":[{"value":"2 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the ethics committee of Shanxi Province Cancer Hospital (Approval No. 201995), and individual written informed consent for this retrospective analysis was waived by the ethics committee of Shanxi Province Cancer Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}